Literature DB >> 21418107

Therapy-related myelodysplasia in a patient with Rothmund-Thomson syndrome.

Aaron M Carlson1, Noralane M Lindor, Mark R Litzow.   

Abstract

Rothmund-Thomson syndrome (RTS) is a rare autosomal recessive disorder of which approximately 300 cases have been reported in the literature. Patients with RTS often present early in life with skeletal and dental abnormalities, short stature, juvenile cataracts, and a characteristic poikilodermal rash. They are at increased risk for the development of osteosarcoma that usually presents by the second decade of life. The genetic defects underlying RTS are truncating mutations in RECQL4, a gene involved with chromosomal stability. Several cases of primary hematological malignancies have been reported in RTS, but it is unclear whether patients with RTS are at higher risk to develop either primary or secondary hematological malignancies. We report a patient with RTS who presented to our clinic at the age of 7, subsequently developed multifocal and recurrent osteosarcoma that was followed by the development of a myelodysplastic syndrome with subsequent progression to acute myeloid leukemia.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21418107     DOI: 10.1111/j.1600-0609.2011.01609.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  2 in total

Review 1.  Fanconi anaemia and cancer: an intricate relationship.

Authors:  Grzegorz Nalepa; D Wade Clapp
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

2.  The Rothmund-Thomson syndrome helicase RECQL4 is essential for hematopoiesis.

Authors:  Monique F Smeets; Elisabetta DeLuca; Meaghan Wall; Julie M Quach; Alistair M Chalk; Andrew J Deans; Jörg Heierhorst; Louise E Purton; David J Izon; Carl R Walkley
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.